Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer February 2019 19(1):47-57 - Subject
- Language
- ISSN
- 1526-8209